Pelham Keahey retweeted
Paradigm shifting study! Look-forward to future evidence to drive prophylactic treatment of vulnerable plaques and excited for the @SpectraWAVE_Med DeepOCT-NIRS platform to allow for simple identification of high-risk plaques! – at Atlanta, GA
📢Is it time to consider treating non-flow limiting plaques at increased risk of MACE?
PREVENT trial results shared at #ACC2024 today demonstrated improved clinical outcomes at 2 yrs when performing preventative PCI on high-risk plaques vs. medical therapy alone.
Learn more about how SpectraWAVE’s HyperVue Imaging System can identify patients and plaques at increased risk of major adverse cardiac events at spectrawave.com
Read full publication here: thelancet.com/journals/lance…
Pelham Keahey retweeted
Landmark publication from @thelancet on the benefits of Intravascular Imaging for PCI: 15,964 patients from 22 studies shows reduction of Cardiac Death, MI, ST, TLF, and All Cause Death, when using intravascular imaging-guided PCI vs angio alone
thelancet.com/journals/lance…
Super excited to see clinicians using BiliDx (formally BiliSpec) at MNH in Dar-es-Salaam, Tanzania with great results! @NEST360org
bmcpediatr.biomedcentral.com…
Pelham Keahey retweeted
Today at the #iPCImeeting, Dr. @ziadalinyc for the first time showed our DeepOCT+NIRS images!
We're excited to unveil the rest of our HyperVue Imaging System features at SCAI next month! Come see us at Booth #204.
#ImageWithoutCompromise
Pelham Keahey retweeted
Congrats to @SpectraWAVE_Med on FDA approval of #Hypervue. I’ve used this in humans. Can’t remember the last time I saw an an OCT and thought “what’s that?”. Unbelievable image quality. @ESHLOF @GreggWStone @DrAllenJ @JWMoses @djc795 @OKhaliqueMD @CathElectroSurg @FernanOCT
A great day for @SpectraWAVE_Med and the future patients we will serve. Thankful to work with an incredible team to bring our vision to a reality!
#spectrawave #Hypervue #deepoct #nirs #coronaryarterydisease
Pelham Keahey retweeted
Registration is now open for NESBO 2022! Join us on 11/10 to have the opportunity to interact with researchers from across the greater New England Biomedical Optics community octresearch.org/nesbo-22-thu…
Pelham Keahey retweeted
Great visit to the new @Hatch4Newborns office. What a tremendous team they have built!
In the near future, you are going to be able to type the actors, director, and genre into an AI movie generator and watch a movie.
1
Pelham Keahey retweeted
Physics Safety Tip xkcd.com/2662
Pelham Keahey retweeted
Some of the Technologies being showcased in Kigali during interagency #ENAP + #EMPP meeting. @NEST360org @HadleighHealth @LaerdalGH @UNICEFhealth @UNFPA
Pelham Keahey retweeted
Asking Scientists Questions xkcd.com/2655/ m.xkcd.com/2655/
Pelham Keahey retweeted
75% of deaths associated w/ neonatal jaundice occur in sub-Saharan Africa & South Asia bc reliable methods to detect/monitor bilirubin are unavailable
Our new paper evaluates BiliSpec: a low-cost, point-of-care bilirubinometer developed @NEST360org
publications.aap.org/pediatr…
Pelham Keahey retweeted
It was an absolute pleasure working with our partners Hatch Technologies @Hatch4Newborns & Mediglobe at KPA ASC 2022 @Kenyapaeds. BiliDx Bilirubinometer is launched and will be in use later this month! #NEST360
Pelham Keahey retweeted
Data Trap xkcd.com/2582
Pelham Keahey retweeted
Control Group xkcd.com/2576
Hope @NASAWebb didn't need this one, but it looks great! @CoherentInc
Pelham Keahey retweeted
A plea for better working conditions for young scientists by @NeilLewisJr
We have to take action
Need leaders to step up & work w/ young scientists on improving conditions in our collective system
@ScienceMagazine #science #engineering #medicine #research
science.org/content/article/…
Pelham Keahey retweeted
Decorative Constants xkcd.com/2566
Neat article on obtaining a faculty position in STEM at a research-intensive institution for those interested. ncbi.nlm.nih.gov/pmc/article…































